Veterans' 'Forever Chemical' levels may drop with cholesterol drug
NCT ID NCT07592858
First seen May 21, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tests whether a cholesterol-lowering drug called colesevelam can reduce levels of harmful PFAS (forever chemicals) in veterans. About 50 veterans with high PFAS levels will receive either the drug or a placebo for several months. Researchers will measure changes in blood PFAS and cholesterol to see if the drug helps the body remove these chemicals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENVIRONMENTAL EXPOSURES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Robley Rex VA Medical Center
Louisville, Kentucky, 40245, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
VA Maine Healthcare System
Augusta, Maine, 04330, United States
-
VA Maine Healthcare System
Augusta, Maine, 04330, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.